Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$45.82 - $56.9 $1,420 - $1,763
-31 Reduced 0.51%
6,015 $306,000
Q3 2021

Nov 10, 2021

BUY
$43.79 - $55.78 $15,764 - $20,080
360 Added 6.33%
6,046 $337,000
Q1 2021

May 13, 2021

SELL
$40.32 - $50.97 $29,030 - $36,698
-720 Reduced 11.24%
5,686 $237,000
Q4 2020

Feb 16, 2021

SELL
$41.72 - $51.34 $17,230 - $21,203
-413 Reduced 6.06%
6,406 $298,000
Q3 2020

Nov 13, 2020

SELL
$37.02 - $51.28 $15,400 - $21,332
-416 Reduced 5.75%
6,819 $290,000
Q2 2020

Aug 14, 2020

BUY
$43.24 - $55.02 $312,841 - $398,069
7,235 New
7,235 $347,000
Q3 2018

Nov 13, 2018

SELL
$66.65 - $83.86 $1.89 Million - $2.37 Million
-28,300 Closed
0 $0
Q2 2018

Aug 13, 2018

SELL
$51.25 - $76.62 $5.42 Million - $8.1 Million
-105,722 Reduced 78.88%
28,300 $2.14 Million
Q1 2018

May 14, 2018

BUY
$52.16 - $66.86 $21,385 - $27,412
410 Added 0.31%
134,022 $7.06 Million
Q4 2017

Feb 13, 2018

BUY
$49.6 - $60.87 $365,056 - $448,003
7,360 Added 5.83%
133,612 $7.14 Million
Q3 2017

Nov 13, 2017

SELL
$46.62 - $60.36 $1.02 Million - $1.32 Million
-21,924 Reduced 14.8%
126,252 $7.53 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-16,083 Reduced 9.79%
148,176 $11.7 Million
Q1 2017

Apr 17, 2019

BUY
N/A
62,223 Added 60.98%
164,259 $13.6 Million
Q4 2016

Apr 17, 2019

SELL
N/A
-6,472 Reduced 5.96%
102,036 $8.1 Million
Q3 2016

Apr 17, 2019

BUY
N/A
108,508
108,508 $7.6 Million

Others Institutions Holding EGRX

About EAGLE PHARMACEUTICALS, INC.


  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.81M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.